Epitomee Medical Ltd (TLV: EPIT)

Market Cap	279.57M
Revenue (ttm)	37.17M
Net Income (ttm)	9.90M
Shares Out	29.57M
EPS (ttm)	0.32
PE Ratio	29.68
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	77,575
Open	940.00
Previous Close	945.40
Day's Range	900.00 - 941.50
52-Week Range	249.40 - 1,595.00
Beta	0.92
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Epitomee Medical

Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 42
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: EPIT

Financial Performance

Financial numbers in USD